Seattle Genetics (SGEN) To Offer Common Shares
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Join SI Premium – FREE
Seattle Genetics, Inc. (Nasdaq: SGEN) announced that they will be making a common stock offering.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Jefferies & Company, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the proposed offering. Leerink Swann LLC and RBC Capital Markets, LLC are acting as co-lead managers for the proposed offering. Needham & Company, LLC, William Blair & Company, LLC, Oppenheimer & Co. Inc. and ThinkEquity LLC are acting as co-managers for the proposed offering.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Jefferies & Company, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the proposed offering. Leerink Swann LLC and RBC Capital Markets, LLC are acting as co-lead managers for the proposed offering. Needham & Company, LLC, William Blair & Company, LLC, Oppenheimer & Co. Inc. and ThinkEquity LLC are acting as co-managers for the proposed offering.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
William Blair, JPMorgan, Jefferies & Co, Needham & Company, ThinkEquity, RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
